Clinical Trial Update: Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immune response to Shingrix in people living with HIV over 50 compared to age-matched controls; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Calmy Alexandra | Conditions: RZV Vaccine (Shingrix ®) | Phase 4 | Status: ACTIVE_NOT_RECRUITING